What process is inhibited by selective serotonin reuptake inhibitors (SSRIs)?

What process is inhibited by selective serotonin reuptake inhibitors (SSRIs)?

• A. Release of serotonin
• B. Uptake of serotonin back into the presynaptic neuron
• C. Synthesis of serotonin
• D. Binding of serotonin to receptors

Answer: (B)

Selective serotonin reuptake inhibitors (SSRIs) function by specifically inhibiting the reuptake of serotonin into the presynaptic neuron. Normally, serotonin is released into the synaptic cleft and binds to receptors on the postsynaptic neuron to exert its effects. After its action, serotonin is transported back into the presynaptic neuron by a serotonin transporter protein, which effectively reduces its availability in the synaptic cleft. By blocking this reuptake process, SSRIs increase the concentration of serotonin in the synaptic cleft, enhancing its neurotransmission and contributing to improvements in mood and emotional regulation. This mechanism is primarily how SSRIs exert their therapeutic effects in the treatment of depression and anxiety disorders. The other processes listed—such as the release of serotonin, its synthesis, and its binding to receptors—are not inhibited by SSRIs. Instead, SSRIs specifically target the reuptake process to enhance serotonin levels in the synapse.

Selective serotonin reuptake inhibitors (SSRIs) function by specifically inhibiting the reuptake of serotonin into the presynaptic neuron. Normally, serotonin is released into the synaptic cleft and binds to receptors on the postsynaptic neuron to exert its effects. After its action, serotonin is transported back into the presynaptic neuron by a serotonin transporter protein, which effectively reduces its availability in the synaptic cleft.

By blocking this reuptake process, SSRIs increase the concentration of serotonin in the synaptic cleft, enhancing its neurotransmission and contributing to improvements in mood and emotional regulation. This mechanism is primarily how SSRIs exert their therapeutic effects in the treatment of depression and anxiety disorders.

The other processes listed—such as the release of serotonin, its synthesis, and its binding to receptors—are not inhibited by SSRIs. Instead, SSRIs specifically target the reuptake process to enhance serotonin levels in the synapse.